B J Kerns

Title: B J Kerns: Innovator in Molecular Diagnostics

Introduction

B J Kerns is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of molecular diagnostics, particularly in the assessment of melanocytic lesions. His work has implications for the early detection of melanoma, a critical aspect of cancer treatment.

Latest Patents

B J Kerns holds a patent for "Molecular malignancy in melanocytic lesions." This patent discloses methods for determining whether a melanocyte-containing sample, such as a nevus or other pigmented lesion, is benign or a primary melanoma. The methods include detecting the expression of at least two disclosed genes at the molecular level, such as mRNA, miRNA, or protein, in a biological sample obtained from a subject. Additionally, the patent provides arrays and kits that can be utilized with these methods.

Career Highlights

Throughout his career, B J Kerns has worked with several prominent organizations. He has been associated with Htg Molecular Diagnostics, Inc. and the John Wayne Cancer Institute. His experience in these institutions has allowed him to advance his research and contribute to the field of molecular diagnostics.

Collaborations

B J Kerns has collaborated with notable professionals in his field, including Hui Wang and Christopher Roberts. These collaborations have likely enriched his research and contributed to the development of innovative diagnostic methods.

Conclusion

B J Kerns is a distinguished inventor whose work in molecular diagnostics has the potential to improve the early detection of melanoma. His patent and career achievements reflect his commitment to advancing medical science and enhancing patient care.